Project description
New treatment for bladder cancer
Roughly 175 000 Europeans receive a diagnosis of bladder cancer (BC) annually, making it the fifth most prevalent cancer within the EU. The process of diagnosing BC is intricate and time-intensive, while its treatment relies on perilous and antiquated resectoscope surgeries, carrying a substantial risk of recurrence. In this context, the EU-funded Multi4 project strives to introduce the revolutionary Multi4 device and platform. This innovation empowers localised BC treatment through adaptable cystoscopy during the initial consultation with the urologist, encompassing various functions ranging from localised anaesthesia to excising cancerous growths, all within a 20-minute timeframe. The Multi4 groundbreaking technology and its expansion hold the potential to benefit hundreds of thousands of patients.
Objective
Bladder Cancer (BC) is the 5th most common cancer in Europe with the incidence of 175.000 cases annually and has the highest lifetime treatment cost of all cancers. At the diagnostic step, a cystoscope is used. Usually, no biopsies are taken as there are no efficient methods to do so in the outpatient care. If the patient has suspected cancer seen on the monitor, they are scheduled for a surgery. At the surgery step, the biopsies are taken and the cancer is removed using a resectoscope. The procedure is difficult to perform. The instrument used is hard (metal, up to 12 mm in diameter) and inflexible (can damage the urethra). There is a high risk of cancer reseeding elsewhere in the bladder. Up to 75 % of BC patients relapse within 5 years. The related costs in the EU are estimated at € 5 billion annually. No development has taken place since the 1960 when the existing instruments were developed.
We have developed and patented the first medical device (called Multi4) which allows for local treatment of BC through flexible cystoscopy during one visit to the urologist. The instrument has 4 functions:
1. Inject local anaesthesia through a thin needle
2. Pieces of the cancer are cut by the specially coated forceps. Bleeding is stopped immediately.
3. The cancer tissue is automatically transported out through the instrument itself.
4. When the forceps are closed, they become a burning electrode used to burn the surface where the cancer was located and ensure that all cancer cells have been killed.
With the Multi4 platform, the patient can have their cancer treated at the first visit to the urologist. The procedure takes 20 minutes. This technology can thus disrupt the existing healthcare pathways where BC is treated through expensive and complicated surgeries.
The proposed project will develop a go-to-market strategy for this ground-breaking deep tech innovation and empower the female founder to scale the company.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.
- medical and health sciences clinical medicine oncology bladder cancer
- medical and health sciences clinical medicine surgery
- medical and health sciences clinical medicine anaesthesiology
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Keywords
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Project’s keywords as indicated by the project coordinator. Not to be confused with the EuroSciVoc taxonomy (Fields of science)
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
-
HORIZON.3.2 - European innovation ecosystems
MAIN PROGRAMME
See all projects funded under this programme
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
HORIZON-CSA - HORIZON Coordination and Support Actions
See all projects funded under this funding scheme
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
(opens in new window) HORIZON-EIE-2022-SCALEUP-02
See all projects funded under this callCoordinator
Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.
553 13 Jonkoping
Sweden
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.